4.4 Article

Missed opportunities in prevention of cardiovascular disease in primary care: a cross-sectional study

Journal

BRITISH JOURNAL OF GENERAL PRACTICE
Volume 64, Issue 618, Pages E38-E46

Publisher

ROYAL COLL GENERAL PRACTITIONERS
DOI: 10.3399/bjgp14X676447

Keywords

antihypertensive agents; primary health care; primary prevention; risk; secondary prevention; statins

Funding

  1. National Institute for Health Research (NIHR) [RP-PG-0606-1153]
  2. NIHR Birmingham and Black Country Collaboration for Leadership in Applied Health Research and Care
  3. NIHR Professorship
  4. MRC [MR/K022032/1] Funding Source: UKRI
  5. Medical Research Council [MR/K022032/1] Funding Source: researchfish
  6. National Institute for Health Research [NIHR-RP-02-12-015, RP-PG-0606-1153, PB-PG-1207-15042, RP-PG-1209-10051, CDF/01/017] Funding Source: researchfish

Ask authors/readers for more resources

Background Screening cardiovascular disease (CVD) risk is an important part of CVD prevention. The success of screening is dependent on the rigour with which treatments are subsequently prescribed. Aim To establish the extent to which treatment conforms to guidelines. Design and setting Cross-sectional study of anonymised patient records from 19 general practices in the UK. Method Data relating to patient characteristics, including CVD risk factors, risk score and prescribed medication were extracted. CVD risk (thus eligibility for cholesterol and blood pressure-lowering treatment) was calculated using the Framingham equation. Guideline adherence was defined with descriptive statistics and comparisons by age, sex and disease were made using chi(2) tests. Results Of the 34 975 patients (aged 40-74 years) included in this study, 2550 (7%) patients had existing CVD and 12 349 (35%) had a calculable CVD risk or were on treatment. CVD risk was formally assessed in 8390 (24%) patients. Approximately 7929 (64%) patients eligible for primary prevention therapy were being treated appropriately for their CVD risk. Guideline adherence was higher in younger patients (6284 [69%] aged 40-64 years versus 1645 [50%] aged 65-74 years, P< 0.001) and in females (4334 [69%] females versus 3595 [59%] males, P< 0.001). There was no difference in guideline adherence between patients where CVD risk had been recorded and those where CVD was calculable. Guideline adherence in patients with existing CVD was highest in patients with ischaemic heart disease (866 [ischaemic heart disease], 52%, versus 288 [stroke], 46%, versus 276 [other CVD], 39%; P< 0.001). Conclusion There is scope for improvement in assessment and treatment for prevention of CVD in clinical practice. Increasing the uptake of evidence-based treatments would improve the cost-effectiveness of CVD risk screening programmes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rehabilitation

The feasibility of a self-management programme (My Life After Stroke; MLAS) for stroke survivors

V. L. Johnson, L. Apps, E. Kreit, R. Mullis, J. Mant, M. J. Davies

Summary: The study aimed to test the acceptability and feasibility of the self-management programme My Life After Stroke (MLAS), as well as identifying the outcomes measures to include in further testing. The results showed that MLAS was a feasible programme and met the needs of stroke survivors.

DISABILITY AND REHABILITATION (2023)

Article Rehabilitation

The development of a self-management intervention for stroke survivors - My Life After Stroke (MLAS)

Vicki L. Johnson, Lindsay Apps, Michelle Hadjiconstantinou, Marian E. Carey, Elizabeth Kreit, Ricky Mullis, Jonathan Mant, Melanie J. Davies

Summary: This study aimed to develop a structured self-management programme to address the unmet long-term needs of stroke survivors. The programme was developed through a systematic process based on evidence and theory, and involved three phases.

DISABILITY AND REHABILITATION (2023)

Article Peripheral Vascular Disease

Cost-Effectiveness of Antihypertensive Deprescribing in Primary Care: a Markov Modelling Study Using Data From the OPTiMISE Trial

Sue Jowett, Shahela Kodabuckus, Gary A. Ford, F. D. Richard Hobbs, Mark Lown, Jonathan Mant, Rupert Payne, Richard J. McManus, James P. Sheppard

Summary: This study assessed the cost-effectiveness of deprescribing antihypertensive medications for older patients with normal blood pressure. The findings suggest that reducing medication use is not advisable for many older patients with controlled systolic blood pressure, but may be beneficial for high-risk populations with targeted approaches.

HYPERTENSION (2022)

Article Engineering, Electrical & Electronic

Wearable Photoplethysmography for Cardiovascular Monitoring

Peter H. Charlton, Panicos A. Kyriacou, Jonathan Mant, Vaidotas Marozas, Phil Chowienczyk, Jordi Alastruey

Summary: Smart wearables provide an opportunity to monitor health, especially in the detection of cardiovascular disease. By monitoring the photoplethysmogram signal, wearable devices can effectively monitor the heart and blood vessels. This survey summarizes the fundamentals of wearable photoplethysmography, its analysis, potential clinical applications, and outlines future research directions.

PROCEEDINGS OF THE IEEE (2022)

Article Medicine, Research & Experimental

How to embed qualitative research in trials: insights from the feasibility study of the SAFER trial programme

Alison Powell, Sarah Hoare, Rakesh Modi, Kate Williams, Andrew Dymond, Cheryl Chapman, Simon Griffin, Jonathan Mant, Jenni Burt

Summary: Qualitative research can enhance the design, conduct and interpretation of trials. However, its full potential is often not realized in trials. This commentary highlights the contributions of qualitative research to trial design, conduct and day-to-day running, using a feasibility study as an example. Structural factors and relationships play a crucial role in realizing the benefits of embedding qualitative research in trials. Key lessons for planning future trials are outlined.

TRIALS (2022)

Article Medicine, General & Internal

Why do people take part in atrial fibrillation screening? Qualitative interview study in English primary care

Sarah Hoare, Alison Powell, Rakesh Narendra Modi, Natalie Armstrong, Simon J. Griffin, Jonathan Mant, Jenni Burt

Summary: Participants in the study showed overall support for AF screening, viewing it as a positive step towards early diagnosis and better treatment outcomes. They believed that participating in the screening could lead to a better future and demonstrated their commitment to self-care. Most participants perceived the screening test as non-invasive and had low perceived risks, contributing to high uptake rates.

BMJ OPEN (2022)

Review Cardiac & Cardiovascular Systems

What dietary interventions have been tested in heart failure with preserved ejection fraction? A systematic scoping review

Faye Forsyth, Sandra Mulrennan, Jenni Burt, Peter Hartley, Isla Kuhn, Helen Lin, Jonathan Mant, Sapphire Tan, Roy Zhang, Christi Deaton

Summary: This study aims to determine the dietary interventions tested in heart failure with preserved ejection fraction (HFpEF), assess the method of modulation and outcomes employed, and summarize the evidence for any benefit. The study identified 25 clinical investigations, with only 40% conducted exclusively in HFpEF. Most studies used highly tailored prescribed diets or dietary supplementation, while dietary pattern interventions were less common. The study highlights the challenges of pooling heterogeneous studies and the importance of better reporting and standardized definitions and measurements.

EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING (2023)

Article Cardiac & Cardiovascular Systems

Cumulative complexity: a qualitative analysis of patients' experiences of living with heart failure with preserved ejection fraction

Faye Forsyth, Thomas Blakeman, Jenni Burt, Carolyn A. Chew-Graham, Muhammad Hossain, Jonathan Mant, John Sharpley, Emma Sowden, Christi Deaton

Summary: This study investigates the impact of heart failure with preserved ejection fraction (HFpEF) on patients' lives within the context of limited clinical services. The findings suggest that HFpEF patients face a heavy workload and multiple threats, while lacking recognition of their illness. These factors contribute to negative physical, social, and psychological outcomes, as well as a perception of loss of control.

EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING (2023)

Article Primary Health Care

Development of a modified Cambridge Multimorbidity Score for use with SNOMED CT: an observational English primary care sentinel network study

Ruby S. M. Tsang, Mark Joy, Heather Whitaker, James P. Sheppard, John Williams, Julian Sherlock, Nikhil Mayor, Bernardo Meza-Torres, Elizabeth Button, Alice J. Williams, Debasish Kar, Gayathri Delanerolle, Richard McManus, Richard Hobbs, Simon de Lusignan

Summary: This study aimed to develop and validate a modified version of the Cambridge Multimorbidity Score using clinical terms commonly used in electronic health records worldwide. The study used diagnosis and prescriptions data from an English primary care surveillance network and analyzed the associations between 37 health conditions and 1-year mortality risk. Two simplified models were developed and the final model showed good performance in predicting mortality risk.

BRITISH JOURNAL OF GENERAL PRACTICE (2023)

Review Cardiac & Cardiovascular Systems

What are the outcomes of dietary interventions in Heart Failure with preserved Ejection Fraction? A systematic review and meta-analysis

Faye Forsyth, Sandra Mulrennan, Jenni Burt, Peter Hartley, Isla Kuhn, Helen Lin, Jonathan Mant, Sapphire Tan, Roy Zhang, Christi Deaton

Summary: This study aimed to determine the effectiveness of dietary interventions in HFpEF. The analysis of randomized or controlled studies revealed that caloric restriction and carbohydrate restriction led to significant improvements in blood pressure, while protein supplementation improved blood pressure and body weight. However, due to study heterogeneity and overall quality of the evidence, it is difficult to make firm recommendations.

EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING (2023)

Letter Public, Environmental & Occupational Health

The Authors' Reply: Statins and post-stroke dementia

Zhirong Yang, Sengwee Toh, Jonathan Mant

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

An artificial intelligence-based model for prediction of atrial fibrillation from single-lead sinus rhythm electrocardiograms facilitating screening

Tove Hygrell, Fredrik Viberg, Erik Dahlberg, Peter H. Charlton, Katrin Kemp Gudmundsdottir, Jonathan Mant, Josef Lindman Hornlund, Emma Svennberg

Summary: The study aimed to observe the accuracy of an artificial intelligence-based network in predicting paroxysmal atrial fibrillation from a normal sinus rhythm single-lead ECG. The algorithm performed well in predicting paroxysmal AF in a wide age range, but had lower performance in age-homogeneous groups.

EUROPACE (2023)

Article Medicine, General & Internal

The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study

James P. K. Sheppard, Constantinos Koshiaris, Richard Stevens, Sarah A. Lay-Flurrie, Amitava Banerjee, Brandon K. A. Bellows, Andrew J. Clegg, F. D. Richard Hobbs, Rupert A. Payne, Subhashisa Swain, Juliet A. Usher-Smith, Richard J. McManus

Summary: This study found that blood pressure-lowering treatment is associated with an increased risk of serious adverse events, particularly in older and frail patients. The analysis suggests that prescribing new treatment in these populations may be just as likely to cause a serious fall as it would prevent a stroke or heart attack.

PLOS MEDICINE (2023)

Article Health Care Sciences & Services

Why do people choose not to take part in screening? Qualitative interview study of atrial fibrillation screening nonparticipation

Sarah Hoare, Gwilym P. A. Thomas, Alison Powell, Natalie Armstrong, Jonathan Mant, Jenni Burt

Summary: While many individuals feel obligated to participate in screening programs for early treatment of detectable conditions, why some people choose not to participate receives less attention. In a study examining nonparticipation in a national research trial of atrial fibrillation screening, participants who declined the invitation expressed doubts about the necessity and utility of the screening at their age. The study concluded that nonparticipation was based on the consideration of perceived necessity, legitimacy, and utility of the screening.

HEALTH EXPECTATIONS (2023)

Article Primary Health Care

Development of a modified Cambridge Multimorbidity Score for use with SNOMED CT: an observational English primary care sentinel network study

Ruby S. M. Tsang, Mark Joy, Heather Whitaker, James P. Sheppard, John Williams, Julian Sherlock, Nikhil Mayor, Bernardo Meza-Torres, Elizabeth Button, Alice J. Williams, Debasish Kar, Gayathri Delanerolle, Richard McManus, F. D. Richard Hobbs, Simon de Lusignan

Summary: This study developed and validated a modified version of the Cambridge Multimorbidity Score, using clinical terms that are commonly used internationally, allowing reliable estimation across different healthcare settings.

BRITISH JOURNAL OF GENERAL PRACTICE (2023)

No Data Available